Investing.com - Financial Markets Worldwide
Open in App

Bio Solution Co Ltd (086820)

KOSDAQ
Currency in KRW
6,890
+140(+2.07%)
Closed·

086820 Income Statement

Period Ending:
2019
31/12
2020
31/12
2024
31/12
2025
31/12
Total Revenues
8,882.487,744.1912,888.5315,199.89
Total Revenues Growth
--12.81%-+17.93%
Cost Of Revenues
3,032.793,497.784,760.485,631.55
Gross Profit
5,849.694,246.428,128.049,568.34
Gross Profit Growth
--27.41%-+17.72%
Gross Profit Margin %
65.86%54.83%63.06%62.95%
Other Operating Expenses, Total
7,717.377,576.2913,197.2713,908.98
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
--1.83%-+5.39%
3,644.773,229.575,754.756,306.2
3,394.613,534.186,420.556,601.56
137.2147.8735.2634.9
Operating Income
-1,867.68-3,329.88-5,069.22-4,340.64
Operating Income Growth
--78.29%-+14.37%
EBIT Margin %
-21.03%-43%-39.33%-28.56%
Net Interest Expenses
806.531,386.23-1,637.11-2,426.46
Net Interest Expenses Growth
-+71.88%--48.22%
Interest Expense, Total
-52.6-40.48-3,133.42-2,813.74
Interest And Investment Income
859.131,426.711,496.32387.28
Other Non Operating Expenses, Total
16.1140.38-266.232,166.65
EBT, Excl. Unusual Items
-1,045.04-1,903.26-6,972.56-4,600.45
Gain (Loss) On Sale Of Assets
--53.69-1.2
Other Unusual Items, Total
---126.07-8.44
EBT, Incl. Unusual Items
-697.54-1,799.74-11,928.38273.36
EBT, Incl. Unusual Items Growth
--158.01%-+102.29%
EBT, Incl. Unusual Items Margin
-7.85%-23.24%-92.55%1.8%
Income Tax Expense
----
Net Income to Company
-697.54-1,799.74-11,928.38273.36
Minority Interest
----
Net Income
-697.54-1,799.74-11,928.38273.36
Net Income Growth
--158.01%-+102.29%
Net Income Margin %
-7.85%-23.24%-92.55%1.8%
Preferred Dividend and Other Adjustments
----
Net Income to Common Excl. Extra Items
-697.54-1,799.74-11,928.38273.36
Basic EPS - Continuing Operations
-29.57-75.33-49611.33
Basic EPS - Continuing Operations Growth
--154.72%-+102.28%
Diluted EPS - Continuing Operations
-29.67-75.33-49611.32
Diluted EPS - Continuing Operations Growth
--153.93%-+102.28%
Basic Weighted Average Shares Outstanding
23.5923.8924.0524.13
Diluted Weighted Average Shares Outstanding
23.5923.8924.0524.16
Dividend Per Share
----
Dividend Per Share Growth
----
EBITDA
-331.19-1,529.4-3,161.56-2,163.72
EBITDA Growth
--361.79%-+31.56%
EBITDA Margin %
-3.73%-19.75%-24.53%-14.24%
EBIT
-1,867.68-3,329.88-5,069.22-4,340.64
* In Millions of KRW (except for per share items)

FAQ

What was Bio Solution’s revenue at year end?

At the end of the last reported fiscal year, Bio Solution (086820) recorded total revenue of 15,200 million KRW.

How much revenue did Bio Solution report in the most recent quarter?

In its most recent quarterly earnings report, Bio Solution posted revenue of 4,704 million KRW.

What was Bio Solution’s net income for the year?

For the full year, Bio Solution reported net income of 273 million KRW.

How much net income did Bio Solution post in the last quarter?

In the most recent quarter, Bio Solution (086820) posted net income of -736 million KRW.

What was Bio Solution’s gross profit for the year?

Gross profit for the year was reported at 9,568 million KRW.

How much gross profit did Bio Solution generate last quarter?

Bio Solution recorded gross profit of 3,255 million KRW in its latest quarterly report.

What was Bio Solution’s annual operating income?

For the full year, Bio Solution (086820) reported operating income of -4,341 million KRW.

What was Bio Solution’s operating income last quarter?

Quarterly operating income was -482 million KRW.

What was Bio Solution’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 100 million KRW.

What was the quarter-over-quarter change in EBITDA for Bio Solution?

EBITDA changed by 114% million KRW compared to the last quarter.

What is Bio Solution’s most recent gross profit margin?

The latest reported gross profit margin for Bio Solution (086820) is 69% million KRW.

What is Bio Solution’s most recent net income margin?

Net income margin based on recent financials is -16% million KRW.

What is Bio Solution’s most recent EBIT margin?

Bio Solution reported an EBIT margin of -10% million KRW based on current figures.

How did Bio Solution’s revenue change compared to the previous quarter?

Revenue changed by 25% million KRW compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Bio Solution?

In the latest quarter, gross profit changed by 33% million KRW from the previous quarter.
Install Our App
Follow us
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.